Kneat.com Inc
TSX:KSI
Kneat.com Inc
TSX:KSI
Price:
4.26
CAD
0.47%
Market Closed
Market Cap:
CA$408.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kneat.com Inc
TSX:KSI
|
IE |
|
Ovid Therapeutics Inc
NASDAQ:OVID
|
US |
|
IIFL Securities Ltd
NSE:IIFLSEC
|
IN |
|
Suzhou Weizhixiang Food Co Ltd
SSE:605089
|
CN |
|
C
|
CCID Consulting Co Ltd
HKEX:2176
|
CN |
|
Aisan Industry Co Ltd
TSE:7283
|
JP |
|
Milestone Builder Holdings Ltd
HKEX:1667
|
HK |
|
B
|
Business Engineering Corp
TSE:4828
|
JP |
Income Statement
Earnings Waterfall
Kneat.com Inc
Kneat.com Inc
Income Statement
Kneat.com Inc
Kneat.com Inc
Currency: CAD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
3
|
4
|
4
|
4
|
4
|
3
|
|
| Revenue |
16
N/A
|
18
+18%
|
21
+13%
|
23
+10%
|
24
+4%
|
27
+12%
|
29
+9%
|
32
+9%
|
34
+8%
|
37
+8%
|
41
+10%
|
45
+11%
|
49
+9%
|
53
+8%
|
57
+7%
|
60
+6%
|
63
+5%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
(6)
|
(7)
|
(8)
|
(8)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(12)
|
(12)
|
(12)
|
(13)
|
(14)
|
(15)
|
(15)
|
|
| Gross Profit |
9
N/A
|
12
+23%
|
13
+13%
|
15
+11%
|
15
+1%
|
17
+14%
|
19
+12%
|
21
+10%
|
23
+11%
|
26
+11%
|
29
+13%
|
33
+15%
|
37
+10%
|
40
+8%
|
43
+7%
|
45
+6%
|
48
+6%
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(16)
|
(18)
|
(20)
|
(21)
|
(24)
|
(26)
|
(28)
|
(31)
|
(37)
|
(38)
|
(40)
|
(42)
|
(43)
|
(45)
|
(49)
|
(53)
|
(56)
|
|
| Selling, General & Administrative |
(7)
|
(8)
|
(10)
|
(11)
|
(13)
|
(16)
|
(18)
|
(20)
|
(22)
|
(22)
|
(24)
|
(25)
|
(25)
|
(27)
|
(30)
|
(33)
|
(34)
|
|
| Research & Development |
(8)
|
(9)
|
(10)
|
(10)
|
(11)
|
(12)
|
(14)
|
(15)
|
(15)
|
(16)
|
(16)
|
(17)
|
(17)
|
(18)
|
(19)
|
(21)
|
(22)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
3
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(6)
N/A
|
(6)
+5%
|
(7)
-13%
|
(7)
-1%
|
(10)
-42%
|
(9)
+9%
|
(9)
-4%
|
(10)
-7%
|
(14)
-40%
|
(12)
+11%
|
(11)
+11%
|
(8)
+27%
|
(6)
+27%
|
(5)
+14%
|
(6)
-27%
|
(8)
-29%
|
(8)
-1%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(3)
|
(3)
|
(4)
|
(4)
|
1
|
1
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
0
|
(2)
|
3
|
7
|
7
|
6
|
|
| Pre-Tax Income |
(10)
N/A
|
(9)
+7%
|
(11)
-21%
|
(11)
0%
|
(9)
+18%
|
(8)
+11%
|
(10)
-22%
|
(11)
-11%
|
(14)
-32%
|
(15)
-3%
|
(13)
+16%
|
(8)
+39%
|
(8)
+3%
|
(2)
+73%
|
1
N/A
|
(1)
N/A
|
(2)
-127%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(10)
|
(9)
|
(11)
|
(11)
|
(9)
|
(8)
|
(10)
|
(11)
|
(15)
|
(15)
|
(13)
|
(8)
|
(8)
|
(2)
|
0
|
(1)
|
(2)
|
|
| Net Income (Common) |
(10)
N/A
|
(9)
+7%
|
(11)
-21%
|
(11)
0%
|
(9)
+18%
|
(8)
+10%
|
(10)
-22%
|
(11)
-10%
|
(15)
-32%
|
(15)
-3%
|
(13)
+15%
|
(8)
+38%
|
(8)
+2%
|
(2)
+71%
|
0
N/A
|
(1)
N/A
|
(2)
-97%
|
|
| EPS (Diluted) |
-0.13
N/A
|
-0.12
+8%
|
-0.14
-17%
|
-0.14
N/A
|
-0.12
+14%
|
-0.11
+8%
|
-0.13
-18%
|
-0.14
-8%
|
-0.19
-36%
|
-0.19
N/A
|
-0.16
+16%
|
-0.1
+38%
|
-0.09
+10%
|
-0.03
+67%
|
0.01
N/A
|
-0.01
N/A
|
-0.02
-100%
|
|
Switch to:
Switch to:
See Also
Discover More
